Nocturne
Well-known member
https://www.businesswire.com/news/ho...2xq-s.facebook
“”Convincing evidence has emerged from pathophysiological, epidemiological, and genetic studies that Lp(a) is causally related to both CVD, which includes myocardial infarction, stroke, peripheral arterial disease, and heart failure, and CAVD (calcific aortic valve disease).”
Sadly. we do not all live under health care systems where Lp(a) lowering meds are already available for a mere few thousand a year. Hopefully this will change with Ionis’ new drug, still in phase 2 trials.
And hopefully there will be greater awareness that high Lp(a) can cause premature CAVD, so that no one else will come here and be shamed and blamed for being the cause of their AVS by people who feel superior because THEIR AVS had a GENETIC cause.
“”Convincing evidence has emerged from pathophysiological, epidemiological, and genetic studies that Lp(a) is causally related to both CVD, which includes myocardial infarction, stroke, peripheral arterial disease, and heart failure, and CAVD (calcific aortic valve disease).”
Sadly. we do not all live under health care systems where Lp(a) lowering meds are already available for a mere few thousand a year. Hopefully this will change with Ionis’ new drug, still in phase 2 trials.
And hopefully there will be greater awareness that high Lp(a) can cause premature CAVD, so that no one else will come here and be shamed and blamed for being the cause of their AVS by people who feel superior because THEIR AVS had a GENETIC cause.
